Fingerprint
Dive into the research topics where Mark Markowski is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A Star-PEGylation Strategy to Improve Testosterone Pharmacokinetics
Lee, C. B., Tenora, L., Zhang, R., Ranjit, A., Markowski, M. C., Slusher, B. S. & Rais, R., Jan 2026, In: Molecules. 31, 1, 198.Research output: Contribution to journal › Article › peer-review
Open Access -
Castration Resistance Accelerates Prostate Cancer Kinetics
Jonnatan, S., Cavka, L., De Marzo, A. M., Denmeade, S. R., Markowski, M. C., Antonarakis, E. S., Trock, B. J., Marshall, C. H., Madan, R. A., Einstein, D. J. & Sena, L. A., Jun 15 2026, In: Prostate. 86, 9, p. 1021-1027 7 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Comparison of Characteristics and Outcomes of Patients With Metastatic Prostate Cancer With and Without Next-Generation Sequencing Testing
Klugman, M. F., Tsai, H. L., Iranmanesh, Y., Nwigwe, I., Sena, L. A., Eisenberger, M. A., Brawley, O., Mandl, A., Markowski, M. C., Antonarakis, E. S., Paller, C. J., Denmeade, S. R., Carducci, M. A., Canzoniero, J. V., Visvanathan, K. & Marshall, C. H., Feb 2026, In: JCO Oncology Practice. OP-25-00688.Research output: Contribution to journal › Article › peer-review
Open Access -
Comparison of outcomes of contemporary immune-check point inhibitors combinations in Black patients versus White patients with metastatic renal cell carcinoma (mRCC).
Clarke, K., Zahurak, M., Feinaj, A., Markowski, M. C. & Ged, Y., Mar 2026, In: Journal of Clinical Oncology. 44, p. 433 1 p.Research output: Contribution to journal › Article › peer-review
-
Managing patients with recurrent prostate cancer who refuse ADT
Schaffer, K. R. & Markowski, M. C., 2026, (Accepted/In press) In: Nature Reviews Urology.Research output: Contribution to journal › Comment/debate › peer-review